We need radical innovation in clinical trials to reduce cost, shorten timelines, and increase success rates. Generative AI holds significant potential to improve clinical trial outcomes, and has the potential to create $13-$25B in annual value to clinical development, but where do we begin?
To throw a spark on this conversation, the OmniScience team has written a new whitepaper, Field Guide for Modern Clinical Trial Teams.
Our whitepaper takes a deep-dive into complexities of:
› Data unification across multiple sources of truth
› Ever-evolving patient data collection innovations and endpoints
› The role Generative AI can play in making unified clinical trial data immediately actionable
We invite you to explore these insights and more in our whitepaper - download it today and take the next step toward transforming your clinical trial strategy.
